Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Santech ADR | STEC | Nov 1, 2024 | 1.33 | -23.56 |
SAP ADR | SAP | Nov 1, 2024 | 233.11 | -0.23 |
Sapiens | SPNS | Nov 1, 2024 | 37.01 | +0.35 |
Saratoga Investment New | SAR | Nov 1, 2024 | 23.23 | -0.90 |
Sarepta Therapeutics | SRPT | Nov 1, 2024 | 123.29 | -2.15 |
Sasol ADR | SSL | Nov 1, 2024 | 5.72 | +0.18 |
Satellogic A | SATL | Nov 1, 2024 | 0.97 | -1.52 |
SatixFy Communications | SATX | Nov 1, 2024 | 0.78 | +4.21 |
Saul Centers | BFS | Nov 1, 2024 | 38.75 | -1.00 |
Saul Centers Pref D | BFS-D | Nov 1, 2024 | 22.73 | -1.60 |
Saul Centers Pref E | BFS-E | Nov 1, 2024 | 23.42 | +0.30 |
Savara | SVRA | Nov 1, 2024 | 3.60 | -0.96 |
SaverOne 2014 ADR | SVRE | Nov 1, 2024 | 1.40 | -2.78 |
Savers Value Village | SVV | Nov 1, 2024 | 10.28 | +0.49 |
SB Financial Group | SBFG | Nov 1, 2024 | 19.53 | +1.67 |
Sba Communications A | SBAC | Nov 1, 2024 | 225.59 | -1.69 |
SBC Medical Group | SBC | Nov 1, 2024 | 6.86 | 0.00 |
ScanSource | SCSC | Nov 1, 2024 | 43.48 | +2.52 |
SCE Trust III Pref H | SCE-H | Nov 1, 2024 | 25.31 | -0.08 |
SCE Trust V Pref K | SCE-K | Nov 1, 2024 | 24.81 | +0.24 |
SCE Trust VI Pref L | SCE-L | Nov 1, 2024 | 20.40 | -1.02 |
Schlumberger Limited | SLB | Nov 1, 2024 | 39.76 | -0.77 |
SCHMID Group | SHMD | Nov 1, 2024 | 2.87 | -1.03 |
Schneider National | SNDR | Nov 1, 2024 | 28.41 | +0.46 |
Scholar Rock | SRRK | Nov 1, 2024 | 28.42 | -0.07 |
Scholastic | SCHL | Nov 1, 2024 | 24.64 | -0.77 |
Schrodinger | SDGR | Nov 1, 2024 | 17.99 | +2.25 |
Schwab Emrg Mkts Equity ETF | SCHE | Nov 1, 2024 | 28.35 | +0.18 |
Schwab Fundamental Emerging Market | FNDE | Nov 1, 2024 | 31.42 | +0.13 |
Schwab Fundamental International | FNDF | Nov 1, 2024 | 35.61 | +0.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.